The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study)

Background: Severe cases of lymphopenia have been reported during siponimod clinical trials, which may negatively impact its benefit/risk profile. Objective: We aimed to evaluate the incidence of lymphopenia following the initiation of siponimod treatment in clinical practice. The secondary objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sancho-López, Arantxa, Ruiz-Antorán, Belén, Iglesias Hernangómez, Teresa, Ramírez-García, Almudena, Gómez-Estévez, Irene, Sanabria-Cabrera, Judith, Llop Rius, Roser, Pedrós, Consuelo, Campodonico, Diana, Jiménez-Jorge, Silvia, García Luque, Amelia, Costa Frossad França, Lucienne, Montané, Eva, Aldea-Perona, Ana, Téllez Lara, Nieves, Bosch Ferrer, Montserrat, Rodriguez Jiménez, Consuelo, Bonilla-Toyos, Elvira, Sabín Muñoz, Julia, Avendaño-Solá, Cristina, Blasco Quilez, María Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607533/
https://www.ncbi.nlm.nih.gov/pubmed/37892611
http://dx.doi.org/10.3390/jcm12206471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607533/
https://www.ncbi.nlm.nih.gov/pubmed/37892611
http://dx.doi.org/10.3390/jcm12206471

Ejemplares similares